Ishii H, Hiruma K, Morio S, Hirasawa A, Wakita H, Endoh N, Oh H, Yoshida S, Aotsuka N, Asai T
Second Department of Internal Medicine, Chiba University School of Medicine.
Rinsho Ketsueki. 1990 Mar;31(3):330-4.
A 36-year-old male with acute promyelocytic leukemia in second relapse was admitted to receive reinduction therapy in June, 1985, and entered into third complete remission, but he developed spiky fever after chemotherapy. Ultrasonic tomography revealed multiple liver abscesses and culture of the aspirates demonstrated Candida albicans in the abscesses. He was treated with intravenous administration of amphotericin B (AMPH-B) but the effect on the liver abscesses was unsatisfactory and consolidation therapy was difficult to start. AMPH-B (30 mg/day) was administered by percutaneous transhepatic intraportal administration (PTIA). About two months later, multiple liver abscesses disappeared. No remarkable complications such as severe fever, chill and renal dysfunction were recognized during PTIA of AMPH-B. So PTIA of AMPH-B is considered to be useful and safe for the management of fungal liver abscesses.
一名36岁急性早幼粒细胞白血病二次复发的男性患者于1985年6月入院接受再诱导治疗,并进入第三次完全缓解期,但化疗后出现高热。超声断层扫描显示多发性肝脓肿,脓肿穿刺物培养显示脓肿内有白色念珠菌。给予两性霉素B(AMPH-B)静脉滴注治疗,但对肝脓肿的疗效不满意,难以开始巩固治疗。通过经皮经肝门静脉给药(PTIA)给予AMPH-B(30mg/天)。约两个月后,多发性肝脓肿消失。在AMPH-B的PTIA过程中未发现严重发热、寒战和肾功能不全等明显并发症。因此,AMPH-B的PTIA被认为对真菌性肝脓肿的治疗是有效且安全的。